Artigo Acesso aberto Revisado por pares

TGN1412: Time to Change the Paradigm for the Testing of New Pharmaceuticals

2006; SAGE Publishing; Volume: 34; Issue: 2 Linguagem: Inglês

10.1177/026119290603400204

ISSN

2632-3559

Autores

Nirmala Bhogal, Robert D. Combes,

Tópico(s)

Health Systems, Economic Evaluations, Quality of Life

Resumo

Clinical studies in human volunteers are an essential part of drug development. These studies are designed to account for possible differences between the effects of pharmaceutical products in preclinical studies and in humans. However, the tragic outcome of the recent Phase 1 clinical trial on TGN1412 casts considerable doubt over the relevance of this traditional drug development paradigm to the testing of therapeutic agents for human use. The role of alternatives to animal testing is considered, and a series of recommendations are made, which could ensure that clinical trials are well informed and based on the most relevant scientific information.

Referência(s)